Effects of oxidation and reduction on the binding of transcription factors to cis-regulatory elements located in the FGF-4 gene

Molecular Reproduction and Development

Volumn 44, Issue 2, 1996, Pages 146-152

  Lickteig, Kim ^a   Lamb, Kimberly ^a,b   Brigman, Kristen ^a   Rizzino, Angie ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

DNA binding; Embryonal carcinoma cells; Gene expression; Octamer binding proteins; Redox

Indexed keywords

CIS ACTING ELEMENT; DIAMIDE; N ETHYLMALEIMIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYONAL CARCINOMA; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DNA BINDING; TRANSCRIPTION REGULATION;

ALKYLATING AGENTS; ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; DIAMINES; DITHIOTHREITOL; DNA-BINDING PROTEINS; ETHYLMALEIMIDE; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTORS; HOMEODOMAIN PROTEINS; HOST CELL FACTOR C1; MICE; OCTAMER TRANSCRIPTION FACTOR-1; OCTAMER TRANSCRIPTION FACTOR-3; OXIDANTS; OXIDATION-REDUCTION; PROTO-ONCOGENE PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0029942190     PISSN: 1040452X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2795(199606)44:2<146::AID-MRD2>3.0.CO;2-N     Document Type: Article

References (35)

1. Abate C, Patel L, Rauscher III FJ, Curran T (1990): Redox regulation of Fos and Jun DNA-binding activity in Vitro. Science 249:1157-1161.
2. Ammendola R, Mesuraca M, Russo T, Cimino F (1994): The DNA-binding efficiency of Sp1 is affected by redox changes. Eur J Biochem 225:483-489.
3. Baxevanis, A, Landsman, D (1995): The HMG-1 box protein family: Classification and functional relationships. Nucleic Acids Res 23:1604-1613.
4. Bohmann D, Box TJ, Admon A, Nishimura T, Vogt PK, Tjian R (1987): Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238:1386-1392.
5. Bryans M, Lucas J, Knobloch T, Wilkie N, Lang J (1995): Regulation of FGF-4 of enhancer activity by transcription factor NF-Y. Biochem Biophys Res Commun 211:519-527.
6. Dailey L, Yuan H, Basilico C. (1994): Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fribroblast growth factor 4 enhancer. Mol Cell Biol 14:7758-7769.
7. Dignam JD, Lebovitz RM, Roeder RG (1983): Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489.
8. Feldman B, Poueymirou W, Papaiannou VE, DeChiara, TM, Goldfarb M (1995): Requirement of FGF-4 for postimplantation mouse development. Science 267:246-249.
9. Fried M, Croters DM (1981): Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res 9:6505-6525.
10. Hasan S, Koda T, Kakinuma M (1994): An upstream NF-Y-binding site is required for transcriptional activation from the hst promoter in F9 embryonal carcinoma cells. J Biol Chem 269:25042-25048.
11. Huang RP, Adamson ED (1993): Characterization of DNA-binding properties of the Early Growth Response-1 (Egr-1) transcription factor: Evidence for modulation by a redox mechanism. DNA Cell Biol 12:265-273.
12. Hooft van Huijsduijnen R, Yan Li X, Black D, Matthes H, Benoist C, Mathis D (1990): Co-evolution from yeast to mouse: cDNA cloning of the NF-Y (CP-1/CBF) subunits. EMBO J 9:3119-3127.
13. Kadonaga JT, Carner KR, Masiarz FR, Tjian R (1987): Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51:1079-1090.
14. Kado T, Hasan S, Sasaki A, Arimura Y, Kakinuma, M (1994): Regulatory sequences required for hst-1 expression in embryonal carcinoma cells. FEBS Lett 342:71-75.
15. Kelly D, Scholtz B, Orten D, Hinrichs S, Rizzino A (1995): Regulation of the transforming growth factor-β2 gene promoter in embryonal carcinoma cells and their differentiated cells: Differential utilization of transcription factors. Mol Reprod Dev 40:135-145.
16. Laudet V, Stehelin, D, Clevers, H (1993): Ancestry and diversity of the HMG box superfamily. Nucleic Acids Res 21:2493-2501.
17. Ma Y-G, Rosfjord E, Huebert C, Wilder P, Tiesman J, Kelly D, Rizzzino, A (1992): Transcriptional regulation of the murine k-FGF gene in embryonic cell lines. Dev Biol 154:45-54.
18. Martin GR (1981): Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78:7634-7638.
19. Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M, Hamada H (1990): A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60:461-472.
20. Pognonec P, Kato H, Roeder RG (1992): The helix-loop-helix/leucine repeat transcription factor USF can be functionally regulated in a redox-dependent manner. J Biol Chem 267:24563-24567.
21. Pontiggia A, Whitefield S, Goodfellow P, Lovell-Badge R, Bianchi M, (1995): Evolutionary conservation in the DNA-binding and -bending properties of HMG-boxes from SRY proteins of primates. Gene 154:277-280.
22. Rappolee DA, Sturm K, Schultz G, Pedersen R, Werb Z (1990): Expression of growth factor ligands and receptors in preimplantation mouse embryos. In S Heyner, L Wiley (eds): "Early Embryo Development and Paracrine Relationships." New York: Wiley-Liss, pp 11-25.
23. Rigoni P, Xu L, Harshman K, Schaffner W, Arnosti DN (1993): Conserved cysteine residues of Oct-2 POU domain confer sensitivity to oxidation but are dispensable for sequence-specific DNA binding. Biochimica et Biophysica Acta 1173:141-146.
24. Rizzino A, Orme LS, De Larco JE (1983): Embryonal carcinoma cell growth and differentiation production of and response to molecules with transforming growth factor activity. Exp Cell Res 143:143-152.
25. Rizzino A, Sato G (1978): Growth of embryonal carcinoma cells in serum-free medium. Proc Natl Acad Sci USA 75:1844-1848.
26. Rizzino A, Kuszynski C, Ruff E, Tiesman J (1988): Production and utilization of growth factors related to fibroblast growth factor by embryonal carcinoma cells and their differentiated cells. Dev Biol 129:61-71.
27. Rosfjord E, Rizzino A (1994): The octamer motif present in the REX-1 promoter binds Oct-1 and Oct-3 expressed by EC cells and ES cells. Biochem Biophys Res Commun 203:1795-1802.
28. Schöler HR, Rupert S, Suzuki N, Chowdhury K, Gruss P (1990): New type of POU domain in germ line-specific protein Oct-4. Nature 344:435-439.
29. Staal FJT, Roederer M, Herzenberg LA, Herzenberg LA (1990): Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 87:9943-9947.
30. Staal FJT, Roederer M, Israelski DM, Bubp J, Mole LA, McShane D, Deresinski SC, Ross W, Sussman H, Raju PA, Anderson MT, Moore W, Ela SW, Herzenberg LA, Herzenberg LA (1992): Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals. AIDS Res Hum Retroviruses 8:305-311.
31. Sturm RA, Das G, Herr W (1988): The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeobox subdomain. Genes Dev 2:1582-1599.
32. Suzuki N, Rodhewohld H, Neuman T, Gruss P, Schöler HR (1990): Oct-6: A Pou transcription factor expressed in embryonal stem cells and in the developing brain. EMBO J 9:3723-3732.
33. Tiesman J, Rizzino A (1989): Expression and developmental regulation of the k-FGF oncogene in human and murine embryonal carcinoma cells. In Vitro Cell Dev Biol 25:1193-1198.
34. Toledano MB, Leonard WJ (1991): Modulation of transcription factor NF-κB binding activity by oxidation-reduction in Vitro. Proc Natl Acad Sci USA 88:4328-4332.
35. Zheng Yao-Wu, Benedict Yen TS (1994): Negative regulation of Hepatitis B Virus gene expression and replication by oxidative stress. J Biol Chem 269:8857-8862.